NOVEL USE OF ALANYL-GLUTAMINE AND OPHTHALMIC COMPOSITION COMPRISING ALANYL-GLUTAMINE

Title:

NOVEL USE OF ALANYL-GLUTAMINE AND OPHTHALMIC COMPOSITION COMPRISING ALANYL-GLUTAMINE

Document Type and Number:

WIPO Patent Application WO/2023/098537

Kind Code:

A1

Abstract:

A use of alanyl-glutamine in preparation for a drug for treating, relieving or alleviating ocular surface diseases and/or conditions of non-dry eyes. A use of alanyl-glutamine in preparation for a drug for relieving or alleviating visual fatigue. A use of alanyl-glutamine in preparation for a beauty product and health-care product for relieving or alleviating asthenopia.

Inventors:

HUANG JINGFENG (CN)
LIU YANAN (CN)
DU TIELIANG (CN)

Application Number:

PCT/CN2022/133753

Publication Date:

June 08, 2023

Filing Date:

November 23, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SEINDA PHARMACEUTICAL GUANGZHOU CORP (CN)

International Classes:

A61K38/05; A61K9/08; A61K9/10; A61P27/02; A61P27/10

Foreign References:

CN108785251A	2018-11-13
CN109771370A	2019-05-21
CN102573878A	2012-07-11
CN101939000A	2011-01-05
CN106132402A	2016-11-16

Other References:

WANG, LIHUI: "L-alanyl-L-glutamine", BIOACTIVE POLYPEPTIDE CHARACTERISTICS AND NUTRIOLOGY APPLICATION RESEARCH, 30 November 2016 (2016-11-30), XP009546937
ZHAO, HUACHANG AND CHEN, QIU: "Diabetic ocular surface disease", PREVENTION AND TREATMENT OF "FIVE DISORDERS", 31 August 2020 (2020-08-31), XP009546938
ZHAO, JIALIANG: "recurrent corneal epithelial erosion", OPHTHALMOLOGY, 31 October 2014 (2014-10-31), pages 55 - 56, XP009546936

Attorney, Agent or Firm:

BEIJING HAN KUN LAW OFFICES (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD AND APPARATUS FOR RUNNING PROCESS

Next Patent: TRAIN POSITIONING METHOD AND POSITIONING SYSTEM